Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.36 - $3.65 $266,030 - $713,980
-195,611 Reduced 65.67%
102,260 $140,000
Q1 2024

May 15, 2024

BUY
$3.52 - $9.59 $975,289 - $2.66 Million
277,071 Added 1332.07%
297,871 $1.12 Million
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $124,176 - $215,488
20,800 New
20,800 $204,000
Q2 2022

Aug 15, 2022

SELL
$4.02 - $10.43 $1.62 Million - $4.2 Million
-402,217 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $3.28 Million - $8.13 Million
389,169 Added 2982.6%
402,217 $3.66 Million
Q4 2021

Feb 14, 2022

SELL
$19.26 - $30.08 $223,781 - $349,499
-11,619 Reduced 47.1%
13,048 $267,000
Q3 2021

Nov 15, 2021

SELL
$24.86 - $35.02 $539,735 - $760,319
-21,711 Reduced 46.81%
24,667 $630,000
Q2 2021

Aug 16, 2021

BUY
$22.3 - $36.02 $1.03 Million - $1.67 Million
46,378 New
46,378 $1.62 Million
Q1 2021

May 17, 2021

SELL
$26.38 - $51.15 $352,700 - $683,875
-13,370 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$10.5 - $28.5 $191,635 - $520,153
-18,251 Reduced 57.72%
13,370 $347,000
Q3 2020

Nov 16, 2020

SELL
$3.61 - $9.87 $34,432 - $94,140
-9,538 Reduced 23.17%
31,621 $312,000
Q2 2020

Aug 17, 2020

BUY
$2.65 - $4.03 $23,062 - $35,073
8,703 Added 26.81%
41,159 $142,000
Q1 2020

May 15, 2020

SELL
$2.36 - $5.26 $352,600 - $785,880
-149,407 Reduced 82.15%
32,456 $99,000
Q4 2019

Feb 14, 2020

SELL
$4.6 - $5.57 $38,161 - $46,208
-8,296 Reduced 4.36%
181,863 $935,000
Q3 2019

Nov 14, 2019

BUY
$4.99 - $6.16 $948,893 - $1.17 Million
190,159 New
190,159 $981,000
Q4 2018

Feb 14, 2019

SELL
$3.99 - $7.82 $659,630 - $1.29 Million
-165,321 Closed
0 $0
Q3 2018

Nov 01, 2018

BUY
$3.52 - $5.55 $581,929 - $917,531
165,321 New
165,321 $894,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.